Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Pharmacopolitics: Drug Regulation in the United States and Germany

by Arthur A. Daemmrich
Save 17% Save 17%
Current price ₹4,140.00
Original price ₹4,968.00
Original price ₹4,968.00
Original price ₹4,968.00
(-17%)
₹4,140.00
Current price ₹4,140.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9780807872413
  • Binding: Paperback
  • Subject: N/A
  • Publisher: The University of North Carolina Press
  • Publisher Imprint: The University of North Carolina Press
  • Publication Date:
  • Pages: 224
  • Original Price: USD 39.95
  • Language: English
  • Edition: N/A
  • Item Weight: 338 grams
  • BISAC Subject(s): Globalization

Advocates of rapid access to medicines and critics fearful of inadequate testing both argue that globalization will supersede national medical practices and result in the easy transfer of pharmaceuticals around the world. In Pharmacopolitics, Arthur Daemmrich challenges their assumptions by comparing drug laws, clinical trials, and systems for monitoring adverse reactions in the United States and Germany, two countries with similarly advanced systems for medical research, testing, and patient care. Daemmrich proposes that divergent "therapeutic cultures" -- the interrelationships among governments, patients, the medical profession, and the pharmaceutical industry -- underlie national differences and explain variations in pharmaceutical markets and medical care.

Daemmrich carries the United States-Germany comparison from 1950 to the present through case studies of Terramycin (an antibiotic), thalidomide (a sedative), propranolol (a heart medication), interleukin-2 (a cancer therapy), and indinavir (an AIDS drug). He points to different political constructions of "the patient" in the United States and Germany to clarify important differences in government policies and in the distribution of power among key social actors. Daemmrich advises that international regulatory harmonization and globalization in medicine must retain flexibility for social and political variation between countries, even as they achieve technical standardization.

Daemmrich, Arthur A.: - Arthur Daemmrich is assistant professor of business administration at Harvard Business School.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us